- Record: found
- Abstract: not found
- Article: not found
Abstract OT3-1-11: tnAcity: A phase 2/3 randomized study of weekly nab-paclitaxel in combination with either gemcitabine or carboplatin vs gemcitabine/carboplatin as first-line treatment for triple-negative metastatic breast cancer
DA Yardley ,
A Brufsky ,
P Conte ,
J Cortes ,
S Glück ,
J-MA Nabholtz ,
J O'Shaughnessy ,
L Li ,
D Barton ,
A Fandi ,
N Harbeck
March 26 2014
March 26 2014
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.